Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cytosorbents Corporation

    NASDAQ: CTSO · Real-Time Price · USD
    1.18
    -0.04 (-3.28%)
    At close: Jun 17, 2025, 12:19 PM

    Cytosorbents Statistics

    Share Statistics

    Cytosorbents has 62.61M shares outstanding. The number of shares has increased by 0.96% in one year.

    Shares Outstanding

    n/a
    		 62.61M

    Shares Change (YoY)

    n/a
    		 0.96%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 28.16%

    Shares Floating

    n/a
    		 51.94M

    Failed to Deliver (FTD) Shares

    n/a
    		 8,061

    FTD / Avg. Volume

    n/a
    		 8.24%

    Short Selling Information

    The latest short interest is 1.46M, so 2.34% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.46M

    Short % of Shares Out

    n/a
    		 2.34%

    Short % of Float

    n/a
    		 2.54%

    Short Ratio (days to cover)

    n/a
    		 15.62

    Valuation Ratios

    The PE ratio is -2.39 and the forward PE ratio is -15.64. Cytosorbents's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -2.39

    Forward PE

    n/a
    		 -15.64

    PS Ratio

    n/a
    		 1.39

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 4.46

    P/FCF Ratio

    n/a
    		 -3.37

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cytosorbents.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.2, with a Debt / Equity ratio of 2.42.

    Current Ratio

    n/a
    		 2.2

    Quick Ratio

    n/a
    		 1.92

    Debt / Equity

    n/a
    		 2.42

    Debt / EBITDA

    n/a
    		 -1.4

    Debt / FCF

    n/a
    		 -1.83

    Interest Coverage

    n/a
    		 -12

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $238,889.4

    Profits Per Employee

    n/a
    		 $-139,053.4

    Employee Count

    n/a
    		 149

    Asset Turnover

    n/a
    		 0.75

    Inventory Turnover

    n/a
    		 3.83

    Taxes

    Income Tax

    n/a
    		 -1.69M

    Effective Tax Rate

    n/a
    		 7.55%

    Stock Price Statistics

    The stock price has increased by 50.22% in the last 52 weeks. The beta is 1.05, so Cytosorbents's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.05

    52-Week Price Change

    n/a
    		 50.22%

    50-Day Moving Average

    n/a
    		 0.97

    200-Day Moving Average

    n/a
    		 1.03

    Relative Strength Index (RSI)

    n/a
    		 74.77

    Average Volume (20 Days)

    n/a
    		 97,863

    Income Statement

    In the last 12 months, Cytosorbents had revenue of 35.59M and earned -20.72M in profits. Earnings per share was -0.38.

    Revenue

    n/a
    		 35.59M

    Gross Profit

    n/a
    		 25.13M

    Operating Income

    n/a
    		 -16.79M

    Net Income

    n/a
    		 -20.72M

    EBITDA

    n/a
    		 -19.26M

    EBIT

    n/a
    		 -21.01M

    Earnings Per Share (EPS)

    n/a
    		 -0.38
    Full Income Statement

    Balance Sheet

    The company has 3.28M in cash and 26.89M in debt, giving a net cash position of -23.61M.

    Cash & Cash Equivalents

    n/a
    		 3.28M

    Total Debt

    n/a
    		 26.89M

    Net Cash

    n/a
    		 -23.61M

    Retained Earnings

    n/a
    		 -304.01M

    Total Assets

    n/a
    		 50.78M

    Working Capital

    n/a
    		 15.68M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -14.43M and capital expenditures -284.34K, giving a free cash flow of -14.71M.

    Operating Cash Flow

    n/a
    		 -14.43M

    Capital Expenditures

    n/a
    		 -284.34K

    Free Cash Flow

    n/a
    		 -14.71M

    FCF Per Share

    n/a
    		 -0.27
    Full Cash Flow Statement

    Margins

    Gross margin is 70.59%, with operating and profit margins of -47.16% and -58.21%.

    Gross Margin

    n/a
    		 70.59%

    Operating Margin

    n/a
    		 -47.16%

    Pretax Margin

    n/a
    		 -62.96%

    Profit Margin

    n/a
    		 -58.21%

    EBITDA Margin

    n/a
    		 -54.11%

    EBIT Margin

    n/a
    		 -47.16%

    FCF Margin

    n/a
    		 -41.33%

    Dividends & Yields

    CTSO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CTSO is $10, which is 700% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 700%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 5, 2014. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Dec 5, 2014

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -7.97

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist